Screening for Diabetic Retinopathy

  • David J. Browning


Screening is worthwhile when certain criteria are met: a disease has public health importance; an effective treatment exists; an interval exists within which treatment can effect benefit; and the disease is neither too rare nor too common.1 Screening for diabetes mellitus in those over 40 years of age and screening for diabetic retinopathy (DR) in those with known diabetes mellitus fulfill these criteria.2,3 Beyond improving health-related outcomes, treatment of diabetes and DR is cost effective.4,5,6 Thus, the value of screening for DR is widely recognized. There is, however, controversy regarding the best screening method and screening intervals.7


Diabetic Retinopathy Diabetic Macular Edema Proliferative Diabetic Retinopathy Early Treatment Diabetic Retinopathy Study Fundus Photograph 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Jekel JF, Elmore JG, Katz DL. Epidemiology, Biostatistics, and Preventive Medicine. 1st ed. Philadelphia: WB Saunders; 1996:216–217.Google Scholar
  2. 2.
    Leiter LA, Barr A, Belanger A, et al. Diabetes screening in Canada (DIASCAN) study. Diabetes Care. 2001;24:1038–1043.CrossRefPubMedGoogle Scholar
  3. 3.
    Kuo HK, Hsieh HH, Liu RT. Screening for diabetic retinopathy by one-field, non-mydriatic, 45 degrees digital photography is inadequate. Ophthalmologica. 2005;219:292–296.CrossRefPubMedGoogle Scholar
  4. 4.
    Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial. JAMA. 1996;276:1409–1415.Google Scholar
  5. 5.
    Lin DY, Blumenkranz MS, Brothers RJ, et al. The sensitivity and specificity of single field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol. 2002;134:204–213.CrossRefPubMedGoogle Scholar
  6. 6.
    Tung TH, Shih HC, Chen SJ, et al. Economic evaluation of screening for diabetic retinopathy among Chinese Type 2 diabetics: a community-based study in Kinmen, Taiwan. J Epidemiol. 2008;18:225–233.CrossRefPubMedGoogle Scholar
  7. 7.
    Vijan S, Hofer TP, Hayward RA. Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus. JAMA. 2000;283:889–896.CrossRefPubMedGoogle Scholar
  8. 8.
    Chew EY, Benson WR, Boldt HC, et al. Diabetic Retinopathy Preferred Practice Guidelines. San Francisco: American Academy of Ophthalmology; 2003.Google Scholar
  9. 9.
    Liesenfeld B, Kohner E, Piehlmeier W, et al. A telemedicine approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care. 2000;23:345–348.CrossRefPubMedGoogle Scholar
  10. 10.
    Harvey JN, Craney L, Nagendran S, Ng CS. Towards comprehensive population-based screening for diabetic retinopathy: operation of the North Wales diabetic retinopathy screening programme using a central patient register and various screening methods. J Med Screen. 2006;13:87–92.CrossRefPubMedGoogle Scholar
  11. 11.
    Boucher MC, Nguyen QT, Angioi K. Mass community screening for diabetic retinopathy using a nonmydriatic camera with telemedicine. Can J Ophthalmol. 2005;40:734–742.PubMedGoogle Scholar
  12. 12.
    Raman R, Rani PK, Rachepalle SR, et al. Prevalence of diabetic retinopathy in India. Sankara Nethralaya diabetic retinopathy epidemiology and molecular genetics study report 2. Ophthalmology. 2009;116:311–318.Google Scholar
  13. 13.
    McKay R, McCarty CA, Taylor HR. Diabetic retinopathy in Victoria, Australia: the visual Impairment Project. Br J Ophthalmol. 2000;84:865–870.CrossRefPubMedGoogle Scholar
  14. 14.
    Roy MS. Eye care in African Americans with type 1 Diabetes. The New Jersey 725. Ophthalmology. 2004;111:914–920.CrossRefPubMedGoogle Scholar
  15. 15.
    Moss SE, Klein R, Klein BE. Factors associated with having eye examinations in persons with diabetes. Arch Fam Med. 1995;4:529–534.CrossRefPubMedGoogle Scholar
  16. 16.
    Wang F, Javitt J. Eye care for elderly Americans with diabetes mellitus; failure to meet current guidelines. Ophthalmology. 1996;103:1744–1750.PubMedGoogle Scholar
  17. 17.
    Bresnick GH, Mukamel DB, Dickinson JC, Cole DR. A screening approach to the surveillance of patients with diabetes for the presence of vision-threatening retinopathy. Ophthalmology. 2000;107:19–24.CrossRefPubMedGoogle Scholar
  18. 18.
    Sprafka JM, Fritsche TL, Baker R, et al. Prevalence of undiagnosed eye disease in high-risk diabetic individuals. Arch Intern Med. 1990;150:857–861.CrossRefPubMedGoogle Scholar
  19. 19.
    Wong KC, Wang Z. Prevalence of type 2 diabetes mellitus of Chinese populations in mainland China, Hong Kong, and Taiwan. Diab Res Clin Pract. 2006;73:126–134.CrossRefGoogle Scholar
  20. 20.
    Xie XW, Xu L, Wang YX, Jonas JB. Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006. Graefes Arch Clin Exp Ophthalmol. 2008;246:1519–1526.CrossRefPubMedGoogle Scholar
  21. 21.
    Farley TF, Mandava N, Prall FR, Carsky C. Accuracy of primary care clinicians in screening for diabetic retinopathy using single-image retinal photography. Ann Fam Med. 2008;6:428–434.CrossRefPubMedGoogle Scholar
  22. 22.
    Clark J, Grey R, Lim K, Burns-Cox C. Loss of vision before ophthalmic referral in blind and partially sighted diabetics in Bristol. Br J Ophthalmol. 1994;78:741–744.CrossRefPubMedGoogle Scholar
  23. 23.
    Bek T, Lund-Andersen H, Hansen AB, et al. The prevalence of diabetic retinopathy in patients with screen-detected type 2 diabetes in Denmark: the ADDITION study. Acta Ophthalmologica. 2008;E-pub ahead of print.Google Scholar
  24. 24.
    Deb-Joardar N, Germain N, Thuret G, et al. Screening for diabetic retinopathy by ophthalmologists and endocrinologists with pupillary dilation and a nonmydriatic digital camera. Am J Ophthalmol. 2005;140:814–821.CrossRefPubMedGoogle Scholar
  25. 25.
    Stefansson E, Bek T, Porta M, et al. Screening and prevention of diabetic blindness. Acta Ophthalmol Scand. 2000;78:374–385.CrossRefPubMedGoogle Scholar
  26. 26.
    Boucher MC, Desroches G, Garcia-Salinas R, et al. Teleophthalmology screening for diabetic retinopathy through mobile imaging units within Canada. Can J Ophthalmol. 2008;43:658–668.CrossRefPubMedGoogle Scholar
  27. 27.
    Will JC, German RR, Schurman E, et al. Patient adherence to guidelines for diabetes eye care: results from the Diabetic Eye Disease Follow-up Study. Am J Public Health. 1994;84:1669–1671.CrossRefPubMedGoogle Scholar
  28. 28.
    Moller F, Hansen M, Sjolie AK. Is one 60 degree fundus photograph sufficient for screening of proliferative diabetic retinopathy? Diabetes Care. 2002;24:2083–2085.CrossRefGoogle Scholar
  29. 29.
    Klein R, Klein BEK, Neider MW, et al. Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. Ophthalmology. 1985;92:486–491.Google Scholar
  30. 30.
    Barrie T, MacCuish AC. Assessment of non-mydriatic fundus photography in detection of diabetic retinopathy. BMJ. 1986;293:1304–1305.CrossRefPubMedGoogle Scholar
  31. 31.
    von Wendt G, Summanen P, Hallnais K, et al. Detection of diabetic retinopathy: a comparison between red-free digital images and colour transparencies. Graefes Arch Clin Exp Ophthalmol. 2005;243:427–432.CrossRefGoogle Scholar
  32. 32.
    James M, Turner DA, Broadbent DM, et al. Cost effectiveness analysis of screening for sight threatening diabetic eye disease. BMJ. 2000;320:1627–1631.CrossRefPubMedGoogle Scholar
  33. 33.
    Leese GP, Boyle P, Feng Z, et al. Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care. 2008;31:2131–2135.CrossRefPubMedGoogle Scholar
  34. 34.
    Singer DE, Nathan DM, Fogel HA, Schachat AP. Screening for diabetic retinopathy. Ann Intern Med. 1992;116:660–671.PubMedGoogle Scholar
  35. 35.
    Nathan DM, Fogel HA, Godine JE, et al. Role of the diabetologist in evaluating diabetic retinopathy. Diabetes Care. 1991;14:26–33.CrossRefPubMedGoogle Scholar
  36. 36.
    Stellingwerf C, Hardus PLLJ, Hooymans MM. Assessing diabetic retinopathy using two-field digital photography and the influence of JPEG-compression. Doc Ophthalmol. 2004;108:203–209.CrossRefPubMedGoogle Scholar
  37. 37.
    Klein R, Klein BEK, Moss SE, Cruikshanks KJ. The Wisconsin epidemiologic study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217–1228.PubMedGoogle Scholar
  38. 38.
    Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102:520–526.PubMedGoogle Scholar
  39. 39.
    Lueder GT, Silverstein J, Section on Ophthalmology, et al. Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. Pediatrics. 2005;116:270–273.Google Scholar
  40. 40.
    Lueder GT, Pradhan S, White NH. Risk of retinopathy in children with type 1 diabetes mellitus before 2 years of age. Am J Ophthalmol. 2005;140:930–931.CrossRefPubMedGoogle Scholar
  41. 41.
    Scanlon PH, Foy C, Chen FK. Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening. Br J Ophthalmol. 2008;92:775–778.CrossRefPubMedGoogle Scholar
  42. 42.
    Anderson S, Broadbent DM, Swain JYS, et al. Ambulatory photographic screening for diabetic retinopathy in nursing homes. Eye. 2003;17:711–716.CrossRefPubMedGoogle Scholar
  43. 43.
    Trautner C, Icks A, Haastert B, et al. Incidence of blindness in relation to diabetes. Diabetes Care. 1997;20:1147–1153.CrossRefPubMedGoogle Scholar
  44. 44.
    Sussman E, Tsiaras W, Soper K. Diagnosis of diabetic eye disease. JAMA. 1982;247:3231–3234.CrossRefPubMedGoogle Scholar
  45. 45.
    O'Hare JP, Hopper A, Madhaven C, et al. Adding retinal photography to screening for diabetic retinopathy: a prospective study in primary care. BMJ. 1996;312:679–682.PubMedGoogle Scholar
  46. 46.
    Davies R, Sullivan P, Canning C. Simulation of diabetic eye disease to compare screening policies. Br J Ophthalmol. 1996;80:945–950.CrossRefPubMedGoogle Scholar
  47. 47.
    Pugh JA, Jacobson JM, Van Heuven WA, et al. Screening for diabetic retinopathy. The wide angle retinal camera. Diabetes Care. 1993;16:889–895.CrossRefPubMedGoogle Scholar
  48. 48.
    Harding SP, Broadbent DM, Neoh C, et al. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study. BMJ. 1995;311:1131–1135.PubMedGoogle Scholar
  49. 49.
    Moss SA, Klein R, Kessler SD, Richie KA. Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology. 1985;92:62–67.PubMedGoogle Scholar
  50. 50.
    Swanson M. Retinopathy screening in individuals with type 2 diabetes: who, how, how often, and at what cost – an epidemiologic review. Optometry. J Am Optom Assoc. 2005;76:636–646.Google Scholar
  51. 51.
    Kleinstein RN, Roseman JM, Herman WH, et al. Detection of diabetic retinopathy by optometrists. J Am Optom Assoc. 1987;58:879–882.PubMedGoogle Scholar
  52. 52.
    Schachat AP, Hyman L, Leke C, et al. Comparison of diabetic retinopathy detection by clinical examinations and photograph gradings. Arch Ophthalmol. 1993;111:1064–1070.PubMedGoogle Scholar
  53. 53.
    Emanuele N, Klein R, Moritz T, et al. Comparison of dilated fundus examinations with seven-field stereo fundus photographs in the Veterans Affairs Diabetes Trial. J Diabetes Complications. 2008. doi:10.1016/j.jdiacomp.2008.02.010Google Scholar
  54. 54.
    Kinyoun JL, Martin DC, Fujimoto WY, Leonetti DL. Ophthalmoscopy versus fundus photographs for detecting and grading diabetic retinopathy. Invest Ophthalmol Vis Sci. 1992;33:1888–1893.PubMedGoogle Scholar
  55. 55.
    Williams GA, Scott IU, Haller JA, et al. Single-field fundus photography for diabetic retinopathy screening. A report by the American Academy of Ophthalmology. Ophthalmology. 2004;111:1055–1062.Google Scholar
  56. 56.
    Williams R, Nussey S, Humphrey R, Thompson G. Assessment of non-mydriatic fundus photography in detection of diabetic retinopathy. Br Med J. 1986;293:1140–1142.CrossRefGoogle Scholar
  57. 57.
    Browning DJ, McOwen MD, Bowen RM Jr, O'Marah TL. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology. 2004;111:712–715.CrossRefPubMedGoogle Scholar
  58. 58.
    Scott IU, Bressler BN, Bressler SB, et al. Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema. Retina. 2008;28:36–40.CrossRefPubMedGoogle Scholar
  59. 59.
    Kinyoun J, Barton FB, Fishner MR, et al. Detection of diabetic macular edema: ophthalmoscopy versus photography-early treatment diabetic retinopathy study report number 5. Ophthalmology. 1989;96:746–751.Google Scholar
  60. 60.
    McGinn T, Guyatt G, Cook R, Meade M. Diagnosis: measuring agreement beyond chance. In: Guyatt G, Rennie D, eds. User's Guide to the Medical Literature, 1st ed., Chap. 2C. Chicago: AMA Press; 2002.Google Scholar
  61. 61.
    Murgatroyd H, Ellingford A, Cox A, et al. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Br J Ophthalmol. 2004;88:920–924.CrossRefPubMedGoogle Scholar
  62. 62.
    Chantelau E, Zwecker M, Weiss H, et al. Fundus polaroid screening for diabetic retinopathy. Is one print per patient enough? Diabetes Care. 1989;12:223–226.CrossRefPubMedGoogle Scholar
  63. 63.
    Boucher MC, Gresset JA, Angioi K, Olivier S. Effectiveness and safety of screening for diabetic retinopathy with two nonmydriatic digital images compared with the seven standard stereoscopic photographic fields. Can J Ophthalmol. 2003;38:537–542.Google Scholar
  64. 64.
    Beynat J, Charles A, Astruc K, et al. Screening for diabetic retinopathy in a rural French population with a mobile non-mydriatic camera. Diabetes Metab. 2008;35:49–56.CrossRefPubMedGoogle Scholar
  65. 65.
    The Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122:552–563.CrossRefGoogle Scholar
  66. 66.
    Perrier M, Boucher MC, Angioi K, et al. Comparison of two, three, and four 45 degrees image fields obtained with the Topcon CRW6 nonmydriatic camera for screening for diabetic retinopathy. Can J Ophthalmol. 2003;38:569–574.PubMedGoogle Scholar
  67. 67.
    Deb-Joarder N, Germain N, Thuret G, et al. Systematic screening for diabetic retinopathy with a digital fundus camera following pupillary dilatation in a university diabetes department. Diabet Med. 2007;24:303–307.CrossRefGoogle Scholar
  68. 68.
    Leese GP, Ahmed S, Newton RW, et al. Use of mobile screening unit for diabetic retinopathy in rural and urban areas. BMJ. 1993;306:187–189.CrossRefPubMedGoogle Scholar
  69. 69.
    Herbert HM, Jordan K, Flanagan DW. Is screening with digital imaging using one retinal view adequate? Eye. 2003;17:497–500.CrossRefPubMedGoogle Scholar
  70. 70.
    Taylor DJ, Fisher J, Jacob J, Tooke JE. The use of digital cameras in a mobile retinal screening environment. Diabetes Care. 1999;16:680–686.Google Scholar
  71. 71.
    Peters AL, Davidson MB, Ziel FH. Cost-effective screening for diabetic retinopathy using a nonmydriatic retinal camera in a prepaid health-care setting. Diabetes Care. 1993;16:1193–1195.CrossRefPubMedGoogle Scholar
  72. 72.
    Maberly D, Cruess AF, Barile G, Slakter J. Digital photographic screening for diabetic retinopathy in the James Bay Cree. Ophthalmic Epidemiol. 2002;9:169–178.CrossRefGoogle Scholar
  73. 73.
    Leske MC, Wu SY, Hyman L, et al. Diabetic retinopathy in a black population-the Barbados eye study. Ophthalmology. 1999;106:1893–1899.CrossRefPubMedGoogle Scholar
  74. 74.
    O'Hare JP, Hopper A, Madhaven C, et al. Adding retinal photography to screening for diabetic retinopathy: a prospective study in primary care. BMJ. 1996;312:679–682.PubMedGoogle Scholar
  75. 75.
    Scanlon PH, Foy C, Malhotra R, Aldington SJ. The influence of age, duration of diabetes, cataract, and pupil size on image quality in digital photographic retinal screening. Diabetes Care. 2005;28:2448–2453.CrossRefPubMedGoogle Scholar
  76. 76.
    Maberly D, Morris A, Hay D, et al. A comparison of digital retinal image quality among photographers with different levels of training using a nonmydriatic fundus camera. Ophthalmic Epidemiol. 2004;11:191–197.CrossRefGoogle Scholar
  77. 77.
    Lim MCC, Lee SY, Cheng BCL, et al. Diabetic retinopathy in diabetics referred to a tertiary center from a nationwide screening program. Ann Acad Med Singapore. 2008;37:753–759.PubMedGoogle Scholar
  78. 78.
    Scanlon PH, Carter S, Foy C, et al. An evaluation of the change in activity and workload arising from diabetic ophthalmology referrals following the introduction of a community based digital retinal photographic screening program. Br J Ophthalmol. 2005;89:971–975.CrossRefPubMedGoogle Scholar
  79. 79.
    Pandit RJ, Taylor R. Mydriasis and glaucoma: exploding the myth. Diabet Med. 2000;17:693–699.CrossRefPubMedGoogle Scholar
  80. 80.
    Brown JB, Pedula KL, Summers KH. Diabetic retinopathy. Contemporary prevalence in a well-controlled population. Diabetes Care. 2003;26:2637–2642.CrossRefPubMedGoogle Scholar
  81. 81.
    Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet. 2003;361:195–200.CrossRefPubMedGoogle Scholar
  82. 82.
    Lee PP, Meredith LS, Whitcup SM, et al. A comparison of self-reported utilization of ophthalmic care for diabetes in managed care versus fee-for-service. Retina. 1998;18:356–359.PubMedGoogle Scholar
  83. 83.
    The Diabeties Control and Complications Trial Research Group. Color photography vs fluorescein angiography in the detection of diabetic retinopathy in the diabetes control and complications trial. Arch Ophthalmol. 1987;105:1344–1351.Google Scholar
  84. 84.
    Abdel-Ghafar RA, Morris T. Progress towards automated detection and characterization of the optic disc in glaucoma and diabetic retinopathy. Med Inform Internet Med. 2007;32:19–25.CrossRefPubMedGoogle Scholar
  85. 85.
    Gardner GG, Keating D, Williamson TH, Elliott AT. Automatic detection of diabetic retinopathy using an artificial neural network: a screening tool. Br J Ophthalmol. 1996;80:940–944.CrossRefPubMedGoogle Scholar
  86. 86.
    Chaum E, Karnowski TP, Govindasamy VP, et al. Automated diagnosis of retinopathy by content-based image retrieval. Retina. 2008;28:1463–1477.CrossRefPubMedGoogle Scholar
  87. 87.
    Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996;124:164–169.PubMedGoogle Scholar
  88. 88.
    Dasbach EJ, Fryback DG, Newcomb PA, et al. Cost-effectiveness of strategies for detecting diabetic retinopathy. Med Care. 1991;29:20–39.CrossRefPubMedGoogle Scholar
  89. 89.
    Lairson DR, Pugh JA, Kapadia AS, et al. Cost-effectiveness of alternative methods for diabetic retinopathy screening. Diabetes Care. 1992;15:1369–1377.CrossRefPubMedGoogle Scholar
  90. 90.
    Fong DS, Gottlieh J, Ferris FL III, Klein R. Understanding the value of diabetic retinopathy screening. Arch Ophthalmol. 2001;119:758–760.PubMedGoogle Scholar
  91. 91.
    Porta M, Bandello F. Diabetic retinopathy. A clinical update. Diabetologia. 2002;45:1617–1634.CrossRefPubMedGoogle Scholar
  92. 92.
    McCarty CA, Taylor KI, McKay R, et al. Diabetic retinopathy: effects of national guidelines on the referral, examination, and treatment practices of ophthalmologists and optometrists. Clin Exp Ophthalmol. 2001;29:52–58.CrossRefGoogle Scholar
  93. 93.
    Diabetes Management Program. Improving multiple aspects of diabetes care. NCQA Website. 2009. 4-4-2009.Google Scholar
  94. 94.
    American College of Physicians ADAaAAoO. Screening Guidelines for Diabetic Retinopathy: clinical Guideline. Ann Intern Med. 1992;116:683–685.Google Scholar
  95. 95.
    Kumar N, Goyder E, McKibbin M. The incidence of visual impairment due to diabetic retinopathy in Leeds. Eye. 2006;20:455–459.CrossRefPubMedGoogle Scholar
  96. 96.
    Javitt JC, Canner JK, Frank RG, et al. Detecting and treating retinopathy in patients with type 1 diabetes mellitus. Ophthalmology. 1990;97:483–495.PubMedGoogle Scholar
  97. 97.
    Neubauer AS, Kernt M, Haritoglu C, et al. Nonmydriatic screening for diabetic retinopathy by ultra-widefield scanning laser ophthalmoscopy (Optomap). Graefes Arch Clin Exp Ophthalmol. 2008;246:229–235.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Charlotte Eye Ear Nose & Throat AssociatesCharlotteUSA

Personalised recommendations